MedTrace Logo

Beclomethasone in Healthy Athletes

NCT05352191 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-04-28

No results posted yet for this study

Summary

The present study aims to assess her urine concentration of beclomethasone during and after one week of use according to the World Antidoping agency's regulations. The study will assess utility of dried blood spots to detect use of beclomethasone and the effect approved use of beclomethasone has on endurance performance in healthy (non-asthmatic ) athletes.

Conditions

  • Performance, Detection
  • Doping

Interventions

DRUG

Beclomethasone

inhaled 800ug

Sponsors & Collaborators

  • The Norwegian School of Sport Sciences

    collaborator UNKNOWN

  • The Norwegian Doping Control Laboratory

    collaborator UNKNOWN

  • Western Norway University of Applied Sciences

    lead OTHER

Principal Investigators

  • Amund Riiser, PhD · Western Norway University of Applied Sciences

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-01-01
Completion
2024-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05352191 on ClinicalTrials.gov